Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-057831

Chairman and CEO bought 2,500 shares at an average $1.69 ($4,235)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-09-23 Purchase +1,500 $1.69 $2,535 10,880,147 D
Niihara Yutaka Chairman and CEO 2021-09-24 Purchase +1,000 $1.70 $1,700 10,881,147 D
Open-market purchases · 2,500 sh · avg $1.69 · $4,235
Loading xslF345X03/doc4.xml…